Dr. Rachelle Blackman, Dalhousie University
Management of Refractory ITP and AIHA

Dr. Rachelle Blackman is a clinical Hematologist and Associate Professor at Dalhousie University. She completed her Hematology Fellowship program at Dalhousie University in 2021. She obtained subspecialized training at the University of Texas at the Gulf States Hemophilia and Thrombophilia Center with a focus on bleeding disorders, thrombosis and sickle cell disease. Her clinical interests include hemoglobinopathies, hematology in pregnancy, benign and malignancy hematology.

Dr. Robert Puckrin, University of Calgary
Management of Indolent Lymphoma

Dr. Robert Puckrin is a Hematologist and Clinician Investigator at the Tom Baker Cancer Centre and the University of Calgary in Calgary, Canada. Having obtained his medical degree from McGill University, he completed Internal Medicine training at the University of Toronto and subsequent training in Hematology and Hematopoietic Cell Transplantation and Cellular Therapy at the University of Calgary. His main interests are in lymphoma, stem cell transplantation, CAR-T cells and other immune therapies, clinical trials, and real-world data.

Dr. Ben Lai, University of British Columbia
Update on Antiphospholipid Antibody Syndrome

Dr. Lai is a staff hematologist at Vancouver General Hospital and a Clinical Assistant Professor at the University of British Columbia (UBC). He obtained a PhD in Genetics at UBC and a MD at the University of Toronto. He completed his Internal Medicine Residency, Hematology Fellowship, and Thrombosis Fellowship training at UBC. His research interests include antiphospholipid syndrome and other acquired thrombophilias.